North Springs Resources Corp (NSRS) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
North Springs Resources Corp (NSRS) trades at $0.0001. North Springs Resources Corp. is a development-stage company focused on acquiring and developing mineral resource properties and pharmaceutical/medical technology products. The company is based in Riverview, Florida. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for NSRS: NSRS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NSRS against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NSRS: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bullish.
How is this calculated? →North Springs Resources Corp (NSRS) Healthcare & Pipeline Overview
North Springs Resources Corp., operating in the specialty and generic drug manufacturing industry, focuses on acquiring and developing mineral resource properties alongside pharmaceutical and medical technology ventures, distinguishing itself through a dual-focus strategy in the competitive healthcare landscape while based in Riverview, Florida.
What Is the Investment Thesis for NSRS?
North Springs Resources Corp. presents a speculative investment opportunity due to its dual focus on mineral resources and pharmaceutical/medical technology. With a market capitalization of $0.00 billion and a negative P/E ratio of -4.41, the company's financial performance raises concerns. The high beta of 2.06 indicates significant volatility. Potential catalysts include successful acquisition and development of new pharmaceutical products or positive developments in its mineral resource properties, though these are highly uncertain. The company's OTC listing and limited information availability contribute to a high-risk profile. Investors should carefully consider the lack of dividends and the company's unproven track record in both sectors before investing.
Based on FMP financials and quantitative analysis
NSRS Key Highlights
Market capitalization of $0.00 billion, indicating a micro-cap company with limited resources and higher risk.
- Negative P/E ratio of -4.41, reflecting current unprofitability.
- Beta of 2.06, suggesting the stock is more volatile than the overall market.
- No dividend yield, meaning investors do not receive income from holding the stock.
- Focus on both mineral resource properties and pharmaceutical/medical technology, indicating a diversified but potentially unfocused business strategy.
Who Are NSRS's Competitors?
NSRS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NSRS's Key Strengths?
Diversified focus on both mineral resources and healthcare.
- Potential for high growth if successful in either sector.
- Experienced management team (assuming John E. Vivian has relevant experience).
What Are NSRS's Weaknesses?
Small market capitalization and limited resources.
- OTC listing indicates higher risk and lower liquidity.
- Lack of established market presence and track record.
- Dual focus may dilute resources and expertise.
What Could Drive NSRS Stock Higher?
Potential acquisition of new mineral resource properties.
- Potential development and commercialization of pharmaceutical products.
- Announcement of strategic partnerships with larger companies.
- Progress in clinical trials for pharmaceutical products.
- Exploration and development activities at mineral resource properties.
What Are the Key Risks for NSRS?
Financial-distress signal — its Altman Z-Score of -1.30 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Limited access to capital for development projects.
- Intense competition in both mineral resources and healthcare.
- Stringent regulatory requirements in healthcare.
- Fluctuations in commodity prices.
- Economic downturns affecting demand for products and services.
What Are the Growth Opportunities for NSRS?
- Growth opportunity 1: Successful acquisition and development of mineral resource properties could provide a revenue stream and attract investor interest. The global mining market is valued in the trillions of dollars, offering substantial potential for growth. However, this is contingent on identifying viable properties and securing necessary funding, which is a significant challenge for a company of this size. Timeline for realizing this growth is highly uncertain and dependent on exploration and development success.
- Growth opportunity 2: Development and commercialization of pharmaceutical products could generate significant revenue. The global pharmaceutical market is a multi-billion dollar industry, with opportunities in various therapeutic areas. North Springs Resources needs to identify and develop niche products to compete effectively. This growth opportunity depends on successful clinical trials and regulatory approvals, which typically take several years and require substantial investment.
- Growth opportunity 3: Strategic partnerships with larger pharmaceutical or mining companies could provide access to capital and expertise. Collaborations can accelerate product development and market entry. The success of this strategy depends on identifying suitable partners and negotiating favorable terms. Timeline for forming such partnerships is uncertain and dependent on market conditions and company-specific factors.
- Growth opportunity 4: Expansion into new geographic markets could increase revenue and diversify risk. Emerging markets offer significant growth potential for both mineral resources and pharmaceutical products. However, this requires navigating different regulatory environments and cultural nuances. Timeline for geographic expansion is dependent on market research, regulatory approvals, and resource availability.
- Growth opportunity 5: Leveraging medical technology advancements to develop innovative healthcare solutions. The medical technology industry is rapidly evolving, with opportunities in areas such as diagnostics, wearables, and digital health. North Springs Resources needs to identify and develop technologies that address unmet needs in the market. This growth opportunity depends on technological innovation, regulatory approvals, and market adoption, with a timeline that can vary significantly.
What Are NSRS's Competitive Advantages?
- Limited moat due to small size and lack of established market presence.
- Potential for a niche moat through proprietary technology or unique mineral resource assets.
- Reliance on successful acquisition and development of assets to create a sustainable competitive advantage.
What Does NSRS Do?
North Springs Resources Corp., founded in 2009 and based in Riverview, Florida, initially focused on the evaluation, acquisition, exploration, and development of mineral resource properties. In June 2011, the company changed its name from Aurum Resources Corp. to North Springs Resources Corp., signaling a strategic shift to include the acquisition and development of products and services within the pharmaceutical and medical technology industries. This dual focus reflects an attempt to diversify its portfolio across resource exploration and healthcare sectors. The company's activities in the pharmaceutical and medical technology areas involve identifying and developing various products and services, though specific details on these ventures are not available. North Springs Resources operates within the broader healthcare sector, specifically targeting niche areas within drug manufacturing and medical technology. However, given its small market capitalization and OTC listing, the company faces significant challenges in competing with larger, more established players in these industries. Its success hinges on its ability to effectively identify, acquire, and develop promising assets in both the mineral resource and healthcare domains.
What Products and Services Does NSRS Offer?
- Evaluates mineral resource properties for potential acquisition.
- Acquires and explores mineral resource properties.
- Develops mineral resource properties.
- Acquires pharmaceutical and medical technology products.
- Develops pharmaceutical and medical technology products.
- Aims to commercialize acquired and developed products and services.
How Does NSRS Make Money?
- Acquire mineral resource properties with potential for development.
- Develop and potentially sell or license mineral resource assets.
- Acquire and develop pharmaceutical and medical technology products.
- Generate revenue through the sale of developed products and services.
What Industry Does NSRS Operate In?
North Springs Resources Corp. operates within the Drug Manufacturers - Specialty & Generic industry, a segment of the broader healthcare sector. This industry is characterized by intense competition, stringent regulatory requirements, and continuous innovation. Companies like AXRX, CHHL, DECN, NUNZ, and PRCNF represent the competitive landscape. The market is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. North Springs Resources' ability to carve out a niche depends on its success in developing innovative products and navigating the complex regulatory environment.
Who Are NSRS's Key Customers?
- Potential customers for mineral resources include mining companies and industrial users.
- Potential customers for pharmaceutical products include healthcare providers and patients.
- Potential customers for medical technology products include hospitals and clinics.
Company Profile
North Springs Resources Corp operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Riverview, US. The company is led by CEO John E. Vivian. NSRS has traded publicly since 2011.
Key Financial Metrics
Return on equity for North Springs Resources Corp stands at 0.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -24.6%, showing how much profit it generates from its asset base. Its free cash flow yield is 11.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
North Springs Resources Corp's Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.30 places it in the distress zone, a signal of elevated financial risk.
NSRS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Insider buying has increased recently, indicating confidence from management in the company's future.
- Community sentiment has shifted positively, with discussions highlighting potential growth opportunities in the resource sector.
- Recent announcements about new partnerships have generated excitement among investors, suggesting a forward-looking strategy.
- Market perception is improving as analysts recognize the company's positioning in emerging resource markets.
Bear Case
- Concerns about regulatory hurdles have surfaced, which may impact operational timelines and investor confidence.
- Social media sentiment remains mixed, with some investors expressing skepticism about the company's long-term viability.
- Recent earnings reports have raised questions about profitability, leading to increased caution among traders.
- Overall market volatility has created uncertainty, causing some investors to rethink their positions in resource stocks.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
NSRS Latest News
No recent news available for NSRS.
NSRS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NSRS.
Price Targets
Wall Street price target analysis for NSRS.
NSRS MoonshotScore
What does this score mean?
The MoonshotScore rates NSRS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: John E. Vivian
CEO
Information on John E. Vivian's background is limited. Without further data, it's difficult to provide a comprehensive biography. Further research into his career history, education, and previous roles would be needed to assess his qualifications for leading North Springs Resources Corp.
Track Record: Due to the limited information available, John E. Vivian's track record at North Springs Resources Corp. or previous companies cannot be accurately assessed. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown. Further research is needed to evaluate his performance and contributions.
NSRS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that North Springs Resources Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial reporting, making it difficult for investors to assess their financial health and operational performance. Trading on the OTC Other tier is generally associated with higher risk and greater potential for fraud compared to companies listed on major exchanges like the NYSE or NASDAQ, which have stricter listing standards and regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume and wide bid-ask spread can make it difficult to buy or sell shares.
- Higher potential for fraud and manipulation compared to listed exchanges.
- OTC Other tier listing indicates the company may not meet minimum financial standards.
- Limited analyst coverage and investor interest.
- Verify the company's financial statements, if available.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues involving the company.
- Determine the company's revenue sources and sustainability.
- Company has been in operation since 2009.
- Company has a physical headquarters in Riverview, Florida.
- Company has a CEO (John E. Vivian).
NSRS Healthcare Stock FAQ
What does North Springs Resources Corp do?
North Springs Resources Corp. operates with a dual focus, engaging in both the acquisition and development of mineral resource properties and the development of pharmaceutical and medical technology products. The company aims to identify and acquire promising mineral assets, explore their potential, and develop them for commercial use.
What do analysts say about NSRS stock?
Due to its OTC listing and small market capitalization, North Springs Resources Corp. (NSRS) likely has limited or no analyst coverage. This lack of coverage means there are no readily available analyst ratings, price targets, or consensus estimates for the stock. Investors must rely on their own research and due diligence to assess the company's value and potential.
What are the main risks for NSRS?
North Springs Resources Corp. faces several key risks, including its small market capitalization, OTC listing, and limited financial disclosure. The company's dual focus on mineral resources and healthcare presents operational and strategic challenges. Fluctuations in commodity prices and the success of clinical trials are also significant risk factors.
How does North Springs Resources Corp navigate regulatory approval processes?
Unknown
What revenue streams does North Springs Resources Corp have in healthcare?
North Springs Resources Corp.'s revenue streams in the healthcare sector are currently unclear. As the company is focused on the acquisition and development of pharmaceutical and medical technology products, it is likely that revenue generation is dependent on the successful commercialization of these products.
What are the key factors to evaluate for NSRS?
Evaluate NSRS on fundamentals, analyst consensus, and risk factors. North Springs Resources Corp. presents a speculative investment opportunity due to its dual focus on mineral resources and pharmaceutical/medical technology. Not financial advice.
How frequently does NSRS data refresh on this page?
NSRS's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NSRS's recent stock price performance?
North Springs Resources Corp (NSRS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified focus on both mineral resources and healthcare. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on North Springs Resources Corp., particularly regarding its financial performance and specific projects.
- OTC stocks carry higher risk due to lower liquidity and regulatory oversight.